Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance

Eli Lilly And CoTrade
Vanguard Intermediate Term Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Eli Lilly And Co trades at $1,214.84 (market cap $1.08T), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.18. The key difference: Eli Lilly And Co pays a 0.57% dividend while Vanguard Intermediate Term Corporate Bond ETF pays none. Which is the better fit depends on your goals.

LLYVCIT
Market Cap
$1.08T
Sector
HealthFixed Income
52-Week High
$1.24K$84.82
52-Week Low
$639.43$81.07
Enterprise Value
$1.13T
Dividend Yield
0.57%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY

About Vanguard Intermediate Term Corporate Bond ETF

VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.

Read more on VCIT